[{"address1": "Uppsalalaan 17", "address2": "3rd & 4th floor", "city": "Utrecht", "zip": "3584 CT", "country": "Netherlands", "phone": "31 30 253 8800", "website": "https://www.merus.nl", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; collaboration with Incyte Corporation for the development of MCLA-145; and collaboration with Gilead Sciences, Inc. to discover novel antibody-based trispecific T-cell engagers. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.", "fullTimeEmployees": 172, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sven Ante Lundberg M.D.", "age": 61, "title": "CEO, President & Executive Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1114527, "exercisedValue": 0, "unexercisedValue": 10252539}, {"maxAge": 1, "name": "Mr. Gregory D. Perry", "age": 64, "title": "Chief Financial Officer", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 419102, "exercisedValue": 0, "unexercisedValue": 801494}, {"maxAge": 1, "name": "Mr. Peter B. Silverman J.D.", "age": 46, "title": "EVP, Company Secretary, COO, General Counsel, Chief Intellectual Property Officer & Head of US Legal", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 781842, "exercisedValue": 565022, "unexercisedValue": 1331558}, {"maxAge": 1, "name": "Dr. Hennie  Hoogenboom", "title": "Co-Founder and Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Harry  Shuman", "title": "Chief Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cornelis Adriaan de Kruif Ph.D.", "age": 59, "title": "CTO & Executive VP", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 338395, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cecilia Anna Wilhelmina Geuijen Ph.D.", "title": "Chief Scientific Officer & Senior VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen  Farren", "title": "IR & Corporate Communications Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Audrey  Bergan", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shannon  Campbell", "age": 58, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 47.63, "open": 47.77, "dayLow": 46.75, "dayHigh": 48.095, "regularMarketPreviousClose": 47.63, "regularMarketOpen": 47.77, "regularMarketDayLow": 46.75, "regularMarketDayHigh": 48.095, "payoutRatio": 0.0, "beta": 1.11, "forwardPE": -12.151281, "volume": 514789, "regularMarketVolume": 513643, "averageVolume": 609530, "averageVolume10days": 557430, "averageDailyVolume10Day": 557430, "bid": 47.26, "ask": 47.66, "bidSize": 3, "askSize": 1, "marketCap": 3244494592, "fiftyTwoWeekLow": 37.77, "fiftyTwoWeekHigh": 61.61, "priceToSalesTrailing12Months": 90.18108, "fiftyDayAverage": 41.8223, "twoHundredDayAverage": 48.958424, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2639703040, "profitMargins": 0.0, "floatShares": 58570679, "sharesOutstanding": 68463696, "sharesShort": 7677547, "sharesShortPriorMonth": 8255578, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.1121, "heldPercentInsiders": 0.02042, "heldPercentInstitutions": 1.0756, "shortRatio": 11.9, "shortPercentOfFloat": 0.112799995, "impliedSharesOutstanding": 68463696, "bookValue": 10.278, "priceToBook": 4.6108193, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -244556000, "trailingEps": -4.03, "forwardEps": -3.9, "enterpriseToRevenue": 73.464, "enterpriseToEbitda": -11.554, "52WeekChange": 0.003793478, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 47.33, "targetHighPrice": 109.0, "targetLowPrice": 67.0, "targetMeanPrice": 86.25, "targetMedianPrice": 86.5, "recommendationMean": 1.27778, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 16, "totalCash": 632268032, "totalCashPerShare": 9.235, "ebitda": -228456992, "totalDebt": 11046000, "quickRatio": 7.944, "currentRatio": 8.321, "totalRevenue": 35932000, "debtToEquity": 1.571, "revenuePerShare": 0.584, "returnOnAssets": -0.21595, "returnOnEquity": -0.44601002, "grossProfits": -110148000, "freeCashflow": -109096128, "operatingCashflow": -155524992, "revenueGrowth": 0.067, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -6.1359196, "financialCurrency": "USD", "symbol": "MRUS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1463664600000, "regularMarketChange": -0.24000168, "regularMarketDayRange": "46.75 - 48.095", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 609530, "fiftyTwoWeekLowChange": 9.619999, "fiftyTwoWeekLowChangePercent": 0.25469947, "fiftyTwoWeekRange": "37.77 - 61.61", "fiftyTwoWeekHighChange": -14.220001, "fiftyTwoWeekHighChangePercent": -0.23080671, "fiftyTwoWeekChangePercent": 0.3793478, "earningsTimestampStart": 1740567540, "earningsTimestampEnd": 1741003200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.03, "epsForward": -3.9, "epsCurrentYear": -3.72183, "priceEpsCurrentYear": -12.732984, "fiftyDayAverageChange": 5.5676994, "fiftyDayAverageChangePercent": 0.13312753, "twoHundredDayAverageChange": -1.5684242, "twoHundredDayAverageChangePercent": -0.03203584, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1740171300, "exchange": "NGM", "messageBoardId": "finmb_24929296", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.50431114, "regularMarketPrice": 47.39, "marketState": "REGULAR", "shortName": "Merus N.V.", "longName": "Merus N.V.", "displayName": "Merus", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]